Maryland Practice Instrumental in FDA Approval of New Treatment for Double Chins

Share Article

Maryland Laser Skin and Vein, a top cosmetic dermatology practice, was a principle investigator for Kybella, a new injectable treatment

A double chin can affect anyone regardless of age, and for some people, a double chin can be genetic and resistant to diet and exercise.

Maryland Laser Skin and Vein (MDLSV) was a pivotal player in the FDA approval of Kybella (deoxycholic acid), a new treatment for double chins. The U.S. Food and Drug Administration was awarded regulatory approval for the drug on Wednesday, April 29. Kybella is a Kythera Biopharmaceuticals injectable drug to treat adult “submental fullness” or double chin.

MDLSV physicians will be among a select few dermatological practices in the U.S. offering Kybella treatments to patients. Additionally, Dr. Karen Beasley, MDLSV board-certified dermatologist and principal investigator in the FDA clinical trials, will be training other doctors around the country on the safe use of Kybella.

“As a premiere cosmetic dermatology practice in the Baltimore/D.C. area,” said Dr. Robert Weiss, MDLSV director, “the trial offered us an opportunity to introduce the treatment to our clients. A double chin can affect anyone regardless of age, and for some people, a double chin can be genetic and resistant to diet and exercise.”

Prior to its approval, Kybella was in development for over eight years with19 clinical studies and over 2,600 patients. MDLSV was one of the few practices involved in the studies.

“We are excited to have the opportunity to offer this innovative new technology at our practice,” said Dr. Karen Beasley, MDLSV dermatologist. “A double chin is an unsightly nuisance affecting 7 out of 10 adults and until now, a facelift was the only way to treat it. We have many happy clients so far following the trial phase, and we're excited that now we can extend the treatment to everyone!”

Kybella's effectiveness is based on its ability to destroy fat cells just like deoxycholic acid, a natural substance found in the human body. Kybella is a powerful treatment, and patients should only have Kybella injections from a board-certified dermatologist.

Founded in 1984 by Drs. Robert and Margaret Weiss, Maryland Laser Skin and Vein Institute is the greater Baltimore/D.C. area’s leading medical and aesthetic dermatology practice . In 2000, dermatologist Karen Beasley, MD joined the practice. With over 45 different types of laser and light based therapies, as well as numerous injectable treatments, the board certified dermatologists at Maryland Laser Skin and Vein Institute are experts in treating a wide range of skin conditions, including acne, rosacea, aging skin and non-invasive fat removal.

For additional information about Maryland Laser Skin and Vein Institute, please visit or call 410-666-3960.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Risa Goldman
Goldman Marketing Group
+1 818-861-7092
Email >
Cosmetic Laser Dermatology
Like >